Health Care & Life Sciences » Biotechnology | Arrowhead Pharmaceuticals Corp.

Arrowhead Pharmaceuticals Corp. | Cash Flow

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
31,143.30
58,630.20
91,940.90
81,723.00
34,380.30
54,450.50
Depreciation, Depletion & Amortization
1,751.40
1,345.70
2,336.20
3,260.00
4,690.40
4,699.30
Other Funds
-
-
-
634.20
-
8,405.50
Funds from Operations
19,172.80
40,421.00
69,115.40
70,145.90
22,732.10
41,345.70
Changes in Working Capital
140.00
5,004.70
3,407.80
5,718.40
1,206.80
5,877.80
Net Operating Cash Flow
19,032.80
35,416.40
65,707.60
64,427.50
23,939.00
47,223.40
Capital Expenditures
296.90
1,717.40
1,970.60
3,860.20
7,918.20
Sale of Fixed Assets & Businesses
89.50
10.00
0.50
-
-
Purchase/Sale of Investments
9,313.50
34,774.40
26,091.00
17,308.00
40,726.00
Net Investing Cash Flow
9,521.20
36,481.80
14,120.80
13,447.80
48,644.20
Issuance/Reduction of Debt, Net
214.80
225.40
214.00
217.50
197.80
Net Financing Cash Flow
44,291.20
185,294.30
290.50
55,131.80
12,055.30
Net Change in Cash
15,737.20
113,396.20
51,296.30
4,152.10
60,527.90
Free Cash Flow
19,329.70
37,133.70
67,678.20
68,287.70
31,857.20
Net Assets from Acquisitions
-
-
10,000.00
-
-
Change in Capital Stock
44,506.00
185,519.70
504.50
55,983.60
12,253.10
Other Uses
0.40
-
-
-
-

About Arrowhead Pharmaceuticals

View Profile
Address
225 South Lake Avenue
Pasadena California 91101
United States
Employees -
Website http://www.arrowheadpharma.com
Updated 07/08/2019
Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.